{"paper_id":"8abd1a42-18ad-4d46-a196-8e31da7d57ac","body_text":"The NUTRI-ENDO Clinical Protocol: Standardized PreTreatment Nutraceutical Optimization with Evidence-Based Vitamin-Mineral Matrix for Endometriosis Management\nAuthors/Creators\n- 1. Hudziak Academy\n- 2. Viktoriya Hudziak Reproductive clinic\nDescription\nEndometriosis affects approximately 10% of reproductive-age women and is frequently associated with chronic inflammation, oxidative stress, estrogen dominance, and micronutrient deficiencies. Despite advances in surgical and hormonal therapy, pre-treatment optimization of the metabolic and immunological milieu remains understandardized. Nutraceutical intervention represents a low-risk, evidence-informed adjunct capable of modulating key pathophysiological pathways prior to definitive therapy.\nObjective: To present a standardized, reproducible clinical protocol — NUTRI-ENDO — for pretreatment nutraceutical optimization in endometriosis patients utilizing a structured vitamin-mineral matrix.\nMethods: The protocol was developed through systematic review of randomized controlled trials, metaanalyses, and mechanistic studies (2010–2026) concerning nutraceutical modulation of endometriosisassociated inflammation, angiogenesis, apoptosis dysregulation, and estrogen metabolism. A multidisciplinary panel synthesized evidence into a tiered implementation framework with defined dosing, timing, monitoring parameters, and safety algorithms.\nResults: The NUTRI-ENDO matrix comprises twelve core nutraceutical categories: Vitamin D3, Vitamin E, Vitamin C, methylfolate, methylcobalamin, magnesium, zinc, selenium, omega-3 polyunsaturated fatty acids (EPA/DHA), N-acetylcysteine (NAC), curcumin, and coenzyme Q10. Each component is stratified by pre-treatment phase (Baseline, Priming, Peri-operative/Pre-ART), with explicit dosing ranges, biochemical targets, and contraindication screening.\nThe NUTRI-ENDO protocol offers a practical, evidence-based framework for clinicians to standardize pre-treatment nutraceutical optimization, potentially improving inflammatory markers, pain scores, and treatment responsiveness in endometriosis patients. Prospective validation studies are warranted.\nFiles\nNUTRI-ENDO_Protocol_v_2.0.pdf\nFiles\n(84.5 kB)\n| Name | Size | Download all |\n|---|---|---|\n|\nmd5:598bb027f0102a15e6a7e35d8d6fc11a\n|\n84.5 kB | Preview Download |","source_license":"CC0","license_restricted":false}